Heart Failure Supportive Care in 2015 GIL KIMEL MD, MSC, FRCPC Dept. of Medicine St. Paul’s Hospital.

Slides:



Advertisements
Similar presentations
Prevalence and Predictors of Off-label Use of Cardiac Resynchronization Therapy: A Report from the ICD Registry TM Adam S. Fein * MD, Yongfei Wang ¥ MS,
Advertisements

The Role of Palliative Care in HIV/AIDS Management in Botswana
Practicalities of Palliative Care
Advance Heart Failure Therapy
Patient-reported Measures: KCCQ and CHF outcomes Aanand D. Naik, MD Houston Health Services Research and Development Center of Excellence.
Natale MARRAZZO Francesco SOLIMENE Quando la CRT-P può bastare?
Effects of Multidisciplinary Care of Heart Failure Patients at High Risk for Hospital Admission S. Scott Sutton, Pharm.D. Associate Clinical Professor.
Oncology and Palliative Care: Promoting the Comfort and Cure Model Parag Bharadwaj, MD FAAHPM.
Inpatient Palliative Care: What is it and Why it’s Important Lyra Sihra MD Associate Medical Director Gentiva Hospice.
ICU Care & Communication Bundle
Sudden Cardiac Death in Heart Failure Trial Presented at American College of Cardiology Scientific Sessions 2004 Presented by Dr. Gust H. Bardy SCD-HeFTSCD-HeFT.
A Primer in Palliative Care for the Stroke Team Mohana Karlekar, MD, FACP Medical Director Palliative Vanderbilt University May 15 th 2013.
WHO Collaborating Centre for Public Health Palliative Care Programmes. BARCELONA. III/2011 Institut Clínic Malalties Hematològiques i Oncològiques Palliative.
Heart Failure Whistle Stop Talks No. 2 Classification Implications Susie Bowell BA Hons, RGN Heart Failure Specialist Nurse.
Palliative Care Cost : A look at the evidence
Update on Palliative Care and POLST (Practitioner Orders for Life Sustaining Treatment) Amy Frieman, MD Medical Director, Palliative Care Services Meridian.
Collaborating with Your Local Team (35 minutes) 1.
JONATHAN MANT, MD; ABDALLAH AL-MOHAMMAD, MD; SHARON SWAIN, BA, PHD; AND PHILIPPE LARAMEE,DC,MSC, FOR THE GUIDELINE DEVELOPMENT GROUP CHRIS FONTIMAYOR MS-III.
Heart Failure Ben Starnes MD FACC Interventional Cardiology
ATLAS Clinical Trial Commentary Dr Eric Topol Chairman and Professor, Department of Cardiology Director of the Joseph J Jacobs Center for Thrombosis and.
Heart Failure Jeopardy DrugsSelf-Care Patient Eval Volume Mgt Misc.
Heart Failure: From Failure to Success
Palliative Care “101“. Definition Palliative Care Specialized medical care for people with serious illnesses. It is focused on providing patients with.
EPECEPEC Elements and Gaps in End-of-life Care Plenary 1 The Education in Palliative and End-of-life Care program at Northwestern University Feinberg School.
Treatment of Heart Failure: Beyond Medical Therapy
Making Sense of Prognosis Communication in Heart Failure Using a CAS Framework Patricia H. Strachan RN, PhD Associate Professor, McMaster University School.
EPECEPECEPECEPEC EPECEPECEPECEPEC Facilitating Advance Care Planning Christopher W Pile, MD Section Chief – Palliative Medicine Carilion Clinic Facilitating.
Understanding Hospice, Palliative Care and End-of-life Issues Richard E. Freeman MD.
Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients Assessment.
What is Palliative Care?
Transitioning in to Retirement Spiritual Health and End of Life Planning by Roy O. Elam, III, M.D. Associate Professor of Medicine Medical Director, Vanderbilt.
Why Emergency Physicians Don’t Care about Cardiac Arrest and Should. Robert Swor, DO Professor, Emergency Medicine Oakland University William Beaumont.
Implementing the DxCG Likelihood of Hospitalization Model in Kaiser Permanente Leslee J Budge, MBA
Dementia and Palliative Care. Palliative Care The world health organization (WHO) defines palliative care as the following: Palliative care is an approach.
Transitioning to Palliative Care: Starting the Conversation Dr. José Pereira Head Division of Palliative Care, University of Ottawa Medical Chief, Palliative.
Heart Failure Palliative Care/Heart Failure Audit.
Evolution & Maturation of the Practice of Hospice and Palliative Medicine Charles F. von Gunten, MD, PhD May 16, 2013 Vice President, Medical Affairs Hospice.
M. JESSUP Tenth International Symposium HEART FAILURE & Co. CARDIOLOGY SCIENCE UPDATE FEMALE DOCTORS SPEAKING ON FEMALE DISEASES Milano aprile 2010.
MORTALITY AUDIT Dr S Callin SpR Palliative Medicine Dr L Russon Consultant Palliative Medicine BRI Palliative Care Team.
Patient Description Older people over 60’s who are terminally ill and have no cure for their illness. They usually have less than 6 months to live. Hospice.
Managed Clinical Networks Heart & Stroke Denise W Brown MCN Manager 8 th October eScience Centre Edinburgh.
New Technologies & Challenges in optimizing the “heart health” of Australia Professor Simon Stewart Head, Preventative Cardiology
Practice Support Program End of Life Learning Session 1 1.
Palliative Care In Heart Failure Dr Chi-Chi Cheung Consultant in Palliative Medicine 19 th March 2015.
Advanced Therapies Lee R. Goldberg, MD, MPH Medical Director, Heart Failure and Cardiac Transplant Program University of Pennsylvania.
IS IT POSSIBLE TO REACH « OPTIMAL THERAPY » IN A SPECIALIZED HEART FAILURE CLINIC? Le Boyer A., Gurné O. Cardiologie Cliniques Universitaires St Luc –
Lecture: Introduction to palliative care March 2011 v?
Coastal Hillside Family Medicine.  “All team based care models require some level of change in the roles and responsibilities of individual professionals,
Introduction to Palliative Care Jigar Joshi MBBS Hospice and Palliative Medicine Fellow.
Chapter 36 Chronic Illness, Disability, and End-of-Life Care All Elsevier items and derived items © 2014, 2010, 2006, 2002, Mosby, Inc., an imprint of.
Eric J Robinson, M.D. Cardiologist April 25, 2015
Heart Failure Audit Dr Jenny Welstand Lead Nurse Heart Failure Service Wrexham Maelor Hospital Acknowledgements: North Wales Cardiac Network Dr Richard.
An Introduction to Palliative Care for Health Care Interpreters Cynthia Roat, MPH Anne Kinderman, MD Alicia Fernandez, MD.
A Perspective on Family Medicine and End-of-Life and Palliative Care Peter Selwyn, M.D., M.P.H. Professor and Chairman Department of Family & Social Medicine.
Date of download: 6/26/2016 From: Cost-Effectiveness of Adding Cardiac Resynchronization Therapy to an Implantable Cardioverter- Defibrillator Among Patients.
From: Cost-Effectiveness of Sacubitril-Valsartan Combination Therapy Compared With Enalapril for the Treatment of Heart Failure With Reduced Ejection Fraction.
Dr Dylan Harris Dr Mel Jefferson
Palliative Care: Emergency Room Interaction
Heart Failure Supportive Care in 2016
CTC Clinical Strategy and Cost Committee
TAVI Passed the Exam and is Ready for Clinical Use in Inoperable Patients Disclosures Research Funding and Speaking Honoraria: Edwards Lifesciences.
Deactivating the shocking component of an Implantable Cardioverter Defibrillator (ICD) (When no longer appropriate)
Heart Failure/Late Problems: End of Life Care: Psychology
Canadian Cardiovascular Society Guidelines on the Use of Cardiac Resynchronization Therapy: Evidence and Patient Selection  Derek V. Exner, MD, MPH, David.
OptiLink HF Trial design: Patients with heart failure who underwent implantation of an ICD were randomized to telemonitoring (n = 505) vs. usual care (n.
Community Based Palliative Care
Perspectives in Palliative Care
Benefits and burdens of hospital admissions and their influence on preferences to return to hospital: a mixed methods study Jackie Robinson Nurse Practitioner.
Presentation transcript:

Heart Failure Supportive Care in 2015 GIL KIMEL MD, MSC, FRCPC Dept. of Medicine St. Paul’s Hospital

Disclosures

Objectives Heart Failure Supportive Care Heart Failure Supportive Care Clinic (HFS) ICD Deactivation

Palliative Medicine Palliative – Palliare (Latin) – to cloak Approach to improve QoL of pts. and families facing life- threating illness Physical, psychosocial, spiritual

Palliative Medicine “What has surprised me is how little palliative care has to do with death. The death part is almost irrelevant. Our focus isn’t on dying. Our focus is on quality of life” Dr. Balfour Mount McGill University

Heart Failure Jessup, NEJM 2003 Inability of heart to meet metabolic demands of body

Heart Failure - Reality Impacts QoL and length of life High health care costs ~ $2 billion/ year in Canada 25,000 deaths / year in Canada QoL in NYHA III/IV … ‘trade’ ½ of remaining life to feel better Krum 2009, Lewis 2001

Heart Failure Only cardiac syndrome rising in prevalence Survival rate for HF ≈ Malignancy : 1 yr = 66% 2 yr = 50% 5 yr = 35% Compared to malignancy : Less palliative care Less likely to understand their illness Less likely to plan for death More likely to die in hospital Johnson Postgrad Med 2007; Yeung CMAJ 2012

Heart Failure Medication decreases morbidity and mortality ACE-I, ββ, spironolactone Treatments are palliative: PCI, TAVI, LVAD Many patients die from other concurrent diseases

Heart Failure Patients often have symptoms early Symptoms affect daily activities, work, relationships 2005 ACC / AHA: class 1 recommendations for inclusion of Palliative Medicine in heart failure treatment

Heart Failure NYHA Functional Class:Mortality 1 yr Class I –Without symptoms 5-10% Class II – Symptoms ordinary activity 15-30% Class III – Symptoms < ordinary activity 15-30% Class IV – Symptoms at rest 50-60% Taylor 2003

Characterize survival on HF admissions BC cohort >14,000 patients Survival time measured after first and each hospitalization Number of CHF hospitalization = strong predictor of mortality Setoguchi AHJ 2007

Survival Decreases with Repeated Hospitalizations Setoguchi AHJ 2007

Goodlin JACC. 2009;54: Phases of HF

Heart Failure Supportive Care Clinic (HFS) Established in January 2011 at St. Paul’s Hospital / VGH Pilot Project - Hypothesis

Heart Failure Supportive Care Clinic (HFS) Combines specialties of cardiology and palliative care Out-patients Patients referred by cardiologists Patients not usually candidates for transplant or LVAD All patients are very complex medical patients Advanced Heart Failure – NYHA III or IV All have multisystem disease ALL have moderate to severe symptoms Based on ESAS

Title: Palliative Care on the Heart Failure Team: Mapping Patient and Provider Experiences and Expectations Multicenter: Western, Dalhousie, UBC Data collection –completed

Do Patients Understand Heart Failure? “I understand that you have heart failure, what does that mean to you?” “I understand that you have heart failure, what does that mean to you?”

Transition to Palliative Care Murray 2007

? Better Model  Concurrent Care Standard Heart Failure Treatment Palliative Care

ICD – Implantable Cardioverter - Defibrillator

ICD Deactivation Poor Communication on ICD deactivation > 95% of hospices admit pts with active ICDs > 50% of hospices have had pts shocked ~ 42% of pts have shocking function deactivated 73% no discussion of turning off ICDs Goldstein 2004, 2010

ICD Deactivation Physicians uneasy talking about ICD deactivation Patients don’t want to talk about it either Physicians should advocate for patient Lampert 2010

ICD Deactivation Last weeks of life: 20% receive shocks

ICD Deactivation Follow algorithm for ICD deactivation: Discussion before implantation Review objective of ICD at each visit Worsening CHF (Phase 3)  think about deactivation Phase 3-4  Deactivation Lampert 2010

Conclusions Heart Failure causes symptoms Specialized clinics may have a role in palliative care ICD deactivation in context of Goals of Care Careful communication ListenDiscussReassure